Response rates after ASCT and consolidation based on independent response adjudication committee assessments in the ITT population (N = 458)
| . | After ASCT, n (%) . | After consolidation, n (%) . |
|---|---|---|
| PR or better | 372 (81.2) | 369 (80.6) |
| CR | 202 (44.1) | 230 (50.2) |
| VGPR | 142 (31.0) | 116 (25.3) |
| PR | 28 (6.1) | 23 (5.0) |
| VGPR or better | 344 (75.1) | 346 (75.5) |
| Stable disease | 6 (1.3) | 1 (0.2) |
| Progressive disease | 4 (0.9) | 1 (0.2) |
| Not evaluable | 76 (16.6) | 87 (19.0) |
| . | After ASCT, n (%) . | After consolidation, n (%) . |
|---|---|---|
| PR or better | 372 (81.2) | 369 (80.6) |
| CR | 202 (44.1) | 230 (50.2) |
| VGPR | 142 (31.0) | 116 (25.3) |
| PR | 28 (6.1) | 23 (5.0) |
| VGPR or better | 344 (75.1) | 346 (75.5) |
| Stable disease | 6 (1.3) | 1 (0.2) |
| Progressive disease | 4 (0.9) | 1 (0.2) |
| Not evaluable | 76 (16.6) | 87 (19.0) |